Loading the section
Prices delayed by 15 minutes
Next earnings report: 29 October 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Amneal Pharmaceuticals, Inc. trades on Nasdaq under the ticker AMRX. The company belongs to the Health care sector. The trading history on this page starts on 07 May 2018.
Over the past 52 weeks AMRX has traded between 9.56 $ and 21.18 $. As of 09 October 2026 the price stood 86.87 % of the way from the 52-week low to the high.
Over one year AMRX shares rose 89.67 %; over six months they rose 53.52 %. Volatility over 90 days is 39.55 %. Dividends are not included: this is price change only, as of 09 October 2026.
AMRX trades at a price-to-earnings ratio of 52.9, above the sector median of 24.8. Price to sales is 2.1, below the sector median of 3.9. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 19.65 | 19.72 | 18.97 | 19.65 | 3M |
| 07 October 2026 | 20.24 | 20.53 | 19.53 | 19.65 | 5M |
| 06 October 2026 | 20.53 | 20.60 | 20.00 | 20.30 | 4M |
| 05 October 2026 | 20.43 | 20.59 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
Amneal Pharmaceuticals, Inc. (AMRX) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 3.0bn $, net income was 72.1m $.
This summary is compiled automatically from SEC filings and exchange data.
Amneal Pharmaceuticals, Inc. reported revenue of 3.0B $ and net income of 122M $ over the last four quarters. Net margin is 4.01 %. Revenue changed by +7.62 % year over year. Earnings per share are 0.37 $. Market capitalisation is 6.5B $.
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 20.23 |
| 20.35 |
| 4M |
| 02 October 2026 | 20.19 | 20.54 | 20.00 | 20.30 | 3M |
| 01 October 2026 | 20.13 | 20.26 | 19.61 | 20.07 | 4M |
| 30 September 2026 | 20.29 | 20.50 | 19.98 | 20.14 | 4M |
| 29 September 2026 | 20.43 | 20.78 | 20.06 | 20.20 | 3M |
| 28 September 2026 | 19.55 | 20.63 | 19.43 | 20.50 | 3M |
| 25 September 2026 | 20.00 | 20.00 | 19.33 | 19.77 | 3M |
| 24 September 2026 | 19.29 | 19.86 | 19.19 | 19.81 | 2M |
| 23 September 2026 | 19.70 | 20.17 | 18.74 | 19.33 | 4M |
| 22 September 2026 | 20.00 | 20.01 | 19.14 | 19.50 | 2M |
| 21 September 2026 | 18.96 | 21.18 | 18.78 | 20.16 | 6M |
| 18 September 2026 | 18.12 | 18.81 | 18.06 | 18.71 | 7M |
| 17 September 2026 | 18.56 | 19.18 | 18.12 | 18.28 | 3M |
| 16 September 2026 | 16.65 | 18.30 | 16.56 | 18.08 | 5M |
| 15 September 2026 | 17.22 | 17.25 | 16.58 | 16.65 | 2M |
| 14 September 2026 | 17.11 | 17.30 | 16.98 | 17.22 | 2M |
| 11 September 2026 | 17.00 | 17.11 | 16.73 | 17.01 | 1M |